Evaxion A (EVAX) Return on Capital Employed (2021 - 2025)
Evaxion A posted quarterly Return on Capital Employed of 37.23% for Q4 2025, up 50.62% on a QoQ basis from 75.39% in Q2 2025.
Evaxion A (EVAX) has 5 years of Return on Capital Employed data on file, last reported at 37.23% in Q4 2025.
- For the quarter ending Q4 2025, Return on Capital Employed changed N/A year-over-year to 37.23%; the trailing twelve-month figure through Dec 2025 stood at 37.23% (changed N/A YoY), and the FY2025 full-year result was 57.04%, up 12005.0% from the prior year.
- Return on Capital Employed for Q4 2025 stood at 37.23%, up from 75.39% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 37.23% in Q4 2025 and bottomed at 501.94% in Q2 2024.
- The 5-year median for Return on Capital Employed is 98.25% (2021), against an average of 155.2%.
- The widest annual swing landed in 2024, when Return on Capital Employed tumbled 33167 bps; it then soared 42655 bps in 2025.
- A 5-year view of Return on Capital Employed shows it stood at 92.87% in 2021, then slipped by 30 bps to 120.47% in 2022, then sank by 248 bps to 418.79% in 2023, then fell by 20 bps to 501.94% in 2024, then soared by 93 bps to 37.23% in 2025.
- The last three Return on Capital Employed figures came in at 37.23% (Q4 2025), 75.39% (Q2 2025), and 501.94% (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 450.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 51.73% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -107.40% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 21.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 10.19% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 20.34% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -21.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -37.23% |
| Jun 30, 2025 | -75.39% |
| Jun 30, 2024 | -501.94% |
| Dec 31, 2023 | -418.79% |
| Jun 30, 2023 | -170.27% |
| Dec 31, 2022 | -120.47% |
| Jun 30, 2022 | -79.34% |
| Mar 31, 2022 | -75.29% |
| Dec 31, 2021 | -92.87% |
| Sep 30, 2021 | -103.64% |
| Jun 30, 2021 | -81.31% |
| Mar 31, 2021 | -105.88% |